Beta-blocker therapy and reduction of risk in non-cardiac surgery;Terapia betabloccante e riduzione del rischio nella chirurgia non cardiaca

Italian Heart Journal, Supplementi

Volumn 4, Issue 2, 2002, Pages 96-101

  Passamonti, Enrico ^a   Pirelli, Salvatore ^a  

^a Divisione di Cardiologia   (Italy)

Author keywords

Beta blocker therapy; Ischemic heart disease

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; POSTOPERATIVE COMPLICATION; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK ASSESSMENT; SURGERY;

ADRENERGIC BETA-ANTAGONISTS; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; POSTOPERATIVE COMPLICATIONS; RANDOMIZED CONTROLLED TRIALS; RISK ASSESSMENT; SURGICAL PROCEDURES, OPERATIVE;

EID: 0038348716     PISSN: 15903796     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. Lee TH. Reducing cardiac risk in noncardiac surgery. N Engl J Med 1999; 341: 1838-40.
2. Eagle KA, Berger PB, Calkins H, et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery - executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to update the 1996 guidelines on perioperative cardiovascular evaluation for noncardiac surgery). Circulation 2002; 105: 1257-67.
3. Mori F, Zuppiroli A. Valutazione cardiovascolare preoperatoria nella chirurgia non cardiaca: il ruolo delle indagini strumentali non invasive. Ital Heart J Suppl 2003; 4: 19-27.
4. Eagle KA, Rihai CS, Mickel MC, Holmes DR, Foster ED, Gersh BJ. Cardiac risk of noncardiac surgery: influence of coronary disease and type of surgery in 3368 operations. CASS Investigators and University of Michigan Heart Care Program. Coronary Artery Surgery Study. Circulation 1997; 96: 1882-7.
5. Hassan SA, HIatky MA, Boothroyd DB,et al. Outcomes of noncardiac surgery after coronary bypass surgery or coronary angioplasty in the Bypass Angioplasty Revascularization Investigation (BARI). Am J Med 2001; 110: 260-6.
6. McFalls EO, Ward HB, Krupski WC, et al. Prophylactic coronary artery revascularization for elective vascular surgery: study design. Veterans Affairs Cooperative Study Group on Coronary Artery Revascularization Prophylaxis for Elective Vascular Surgery. Control Clin Trials 1999; 20: 297-308.
7. Metzler H, Gries M, Rehak P, Lang T, Fruhwald S, Toller W. Perioperative myocardial cell injury: the role of troponins. Br J Anaesth 1997; 78: 386-90.
8. Dargie HJ. Effects of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet 2001; 357: 1385-90.
9. Stone JG, Foex P, Sear JW, Johnson LL, Khambatta HJ, Triner L. Myocardial ischemia in untreated hypertensive patients: effect of a single small oral dose of a beta-adrenergic blocking agent. Anesthesiology 1988; 68: 495-500.
10. Mangano DT, Layug EL, Wallace A, Tateo I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. N Engl J Med 1996;335:1713-20.
11. Poldermans D, Boersma E, Bax JJ, et al.The effect of biso-prolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med 1999; 341: 1789-94.
12. Boersma E, Poldermans D, Bax JJ, et al, for the DECREASE Study Group (Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography). Predictors of cardiac events after major vascular surgery: role of clinical characteristics, dobutamine echocardiography, and beta-blocker therapy. JAMA 2001; 285: 1865-73.
13. Auerbach AD, Goldman L. Beta-blockers and reduction of cardiac events in noncardiac surgery: scientific review. JAMA 2002; 287: 1435-44.
14. Shammash JB, Trost JC, Gold JM, Berlin JA, Golden MA, Kimmel SE. Perioperative beta-blocker withdrawal and mortality in vascular surgical patients. Am Heart J 2001; 141: 148-53.
15. Poldermans D, Boersma E, Bax JJ, et al. Bisoprolol reduces cardiac death and myocardial infarction in high-risk patients as long as 2 years after successful major vascular surgery. Eur Heart J 2001; 22: 1353-8.
16. Packer M. Current role of beta-adrenergic blockers in the management of chronic heart failure Am J Med 2001; 110 (Suppl 7A): 81S-94S.
17. Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999; 100: 1043-9.